Complications - OtherDiscriminative Ability of Elixhauser's Comorbidity Measure is Superior to Other Comorbidity Scores for Inpatient Adverse Outcomes After Total Hip Arthroplasty
Section snippets
Patient Sample
Patients for this study were drawn from the 2013 National Inpatient Sample (NIS). The dataset is an approximated sample of 20% of all hospital discharges from the United States. Patients are included regardless if they are insured through Medicare/Medicaid, private insurance, or no insurance at all [25].
The large patient population in NIS allows for sufficient statistical power to draw clinically meaningful conclusions based on a nationally representative population. NIS has the additional
Results
In total, 68,680 patients were identified for the study. Average age was 65.1 ± 11.8 years old (mean ± standard deviation). Over half of the patients were female (55.8%), and 17.1% of patients were obese (Table 3). The summary statistics regarding the studied comorbidity indices demonstrated a median (interquartile range) of 0 (0-1) for the CCI, 2 (1-3) for the ECM, and 0.09 (0-0.09) for the mFI (Table 3).
Approximately 1% of patients experienced some type of CMS-PSCM postoperative general
Discussion
Despite advances in surgical and anesthesia technique, THA is inherently associated with perioperative adverse events [33], [34], [35]. As the demand for THA rises and the elderly population increases, more patients who are older with greater comorbidities will undergo THA procedures [1], [33], [36]. However, despite an increasing number of sicker patients undergoing THA, there is great push toward shorter hospital length of stay following THA in order to reduce healthcare cost [37]. It is
Conclusions
In conclusion, the findings of this study indicate that ECM outperforms CCI and mFI for correctly identifying the probability of the occurrence of several specific and standardized general health adverse outcomes as well as adverse hospital metrics, and that this is mildly improved by considering patient age. The collection of the information necessary to calculate the ECM may help in optimizing clinical pathways and improve controlling for the effect of comorbid diseases in future THA research.
References (47)
- et al.
Simplified frailty index as a predictor of adverse outcomes in total hip and knee arthroplasty
J Arthroplasty
(2016) - et al.
Impact of Charlson indices and comorbid conditions on complication risk in bilateral simultaneous total knee arthroplasty
Knee
(2016) - et al.
Inpatient mortality after primary total hip arthroplasty: analysis from the National Inpatient Sample database
J Arthroplasty
(2015) - et al.
Thirty-day readmission following total hip and knee arthroplasty—a preliminary single institution predictive model
J Arthroplasty
(2014) - et al.
Impact of frailty on outcomes in geriatric femoral neck fracture management: an analysis of national surgical quality improvement program dataset
Int J Surg (London, England)
(2016) - et al.
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
J Chronic Dis
(1987) - et al.
Frailty in elderly people
Lancet (London, England)
(2013) - et al.
Predictors of same-day discharge in primary total joint arthroplasty patients and risk factors for post-discharge complications
J Arthroplasty
(2017) - et al.
Home discharge after primary elective total joint arthroplasty: postdischarge complication timing and risk factor analysis
J Arthroplasty
(2017) - et al.
An assessment of gender-specific risk of implant revision after primary total hip arthroplasty: a systematic review and meta-analysis
J Arthroplasty
(2016)
Basic principles of ROC analysis
Semin Nucl Med
Age as an independent risk factor for postoperative morbidity and mortality after total joint arthroplasty in patients 90 years of age or older
J Arthroplasty
Rapid recovery protocols for primary total hip arthroplasty can safely reduce length of stay without increasing readmissions
J Arthroplasty
American association of hip and knee surgeons-endorsed comorbidity coding for total joint arthroplasty: how often did we hit the mark with International Classification of Diseases, Ninth Revision?
J Arthroplasty
Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030
J Bone Joint Surg Am
Primary total hip arthroplasty: health related quality of life outcomes
Int Orthop
Validation of the Charlson comorbidity index in patients undergoing revision total hip arthroplasty
Int Orthop
Relationship between the Charlson Comorbidity Index and cost of treating hip fractures: implications for bundled payment
J Orthop Traumatol
Inpatient mortality after orthopaedic surgery
Int Orthop
The influence of comorbidity scores on re-operations following primary total hip replacement: comparison and validation of three comorbidity measures
Bone Joint J
The Elixhauser comorbidity method outperforms the Charlson index in predicting inpatient death after orthopaedic surgery
Clin Orthop Relat Res
Association of a modified frailty index with mortality after femoral neck fracture in patients aged 60 years and older
Clin Orthop Relat Res
Comorbidity measures for use with administrative data
Med Care
Cited by (84)
Age-Adjusted Modified Frailty Index: Association With Hip Fracture Discharge Functional Dependence
2024, Journal of Surgical ResearchTrends in deep vein thrombosis prophylaxis after total hip arthroplasty: 2016 to 2021
2024, Journal of OrthopaedicsInferior Outcomes for Patients Transferred Between Surgical Stages for Knee Periprosthetic Joint Infection
2024, Journal of ArthroplastyBisphosphonate Use May be Associated With an Increased Risk of Periprosthetic Hip Fracture
2024, Journal of ArthroplastyComparing Common Risk Assessment Tools to Predict Outcomes in Total Knee Arthroplasty
2024, Journal of Arthroplasty
One or more of the authors of this paper have disclosed potential or pertinent conflicts of interest, which may include receipt of payment, either direct or indirect, institutional support, or association with an entity in the biomedical field which may be perceived to have potential conflict of interest with this work. For full disclosure statements refer to https://doi.org/10.1016/j.arth.2017.08.032.
Ethical Review Committee Statement: This study has been given an exemption from the senior author's Institutional Review Board under federal regulation 45 CFR 46.101(b) (4).